AlloVir Inc (ALVR)
0.781
-0.04
(-4.34%)
USD |
NASDAQ |
May 10, 16:00
0.781
0.00 (0.00%)
After-Hours: 19:56
AlloVir Total Liabilities (Quarterly): 45.02M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 45.02M |
| September 30, 2023 | 52.98M |
| June 30, 2023 | 53.58M |
| March 31, 2023 | 50.51M |
| December 31, 2022 | 52.56M |
| September 30, 2022 | 40.47M |
| June 30, 2022 | 41.86M |
| March 31, 2022 | 39.42M |
| December 31, 2021 | 61.33M |
| Date | Value |
|---|---|
| September 30, 2021 | 49.23M |
| June 30, 2021 | 25.04M |
| March 31, 2021 | 20.91M |
| December 31, 2020 | 17.76M |
| September 30, 2020 | 19.81M |
| June 30, 2020 | 189.14M |
| March 31, 2020 | 15.58M |
| December 31, 2019 | 190.92M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.58M
Minimum
Mar 2020
190.92M
Maximum
Dec 2019
56.83M
Average
45.02M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Protalix BioTherapeutics Inc | 50.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 190.80M |
| Shareholders Equity (Quarterly) | 145.78M |